This page shows the publications co-authored by Ebrahim Barkoudah and Larry Weinrauch.
Wisely Choosing: Aging, Precision, and Medicine. Am J Med. 2018 02; 131(2):e63.
Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus. Ann Intern Med. 2016 08 02; 165(3):225.
Screening for Type 2 Diabetes Mellitus. Ann Intern Med. 2015 Nov 03; 163(9):726.
Getting lost among the guidelines: the difference between patient-focused treatment and population management. Am J Med. 2015 Oct; 128(10):e73.
Letter by Weinrauch and Barkoudah Regarding Article, "Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation. Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry". Circulation. 2015 Feb 03; 131(5):e335.
Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure. N Engl J Med. 2016 Apr 21; 374(16):1521-32.
Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013 Mar 28; 368(13):1210-9.
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA. 2013 Mar 20; 309(11):1125-35.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.